Yes. Odd indeed, although iirc, they later found 935 failed the meet primary because healthy patients usually recovered themselves after day 2 anyways so adminstering them the drug after 48 hrs wasn’t useful … or something to that effect
if now even PED and high risk, which would have weaker immune, also failed to show clinical benefits, that would put the whole RSV program in doubt as one can easily imply 235 will run into same issue as well - Which would make his answer even more odd and somewhat foolish.
Market Data 
Markets 
AI
